Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

South Dakota

Phase 1 cancer trials in South Dakota

13 Phase 1 cancer studies are recruiting participants at sites in 1 city across South Dakota as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every South Dakota city with a recruiting study

By research area: Breast Cancer (4), Lung Cancer (4), Lymphoma (2), Prostate Cancer (2), Melanoma (1).

Sioux Falls (13).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in South Dakota

Basic details from each study's public record (the 12 most recently updated of 13). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Sioux Falls
    Registry record
    NCT06324357 · updated
  2. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Recruiting in
    Sioux Falls
    Registry record
    NCT06270706 · updated
  3. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Recruiting in
    Sioux Falls
    Registry record
    NCT04389632 · updated
  4. A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Day One Biopharmaceuticals, Inc.
    Recruiting in
    Sioux Falls
    Registry record
    NCT05377996 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in South Dakota on ClinicalTrials.gov.

Lung cancer: recently updated in South Dakota

  1. A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT07227597 · updated
  2. KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT04165070 · updated
  3. A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

    • Phase 1
    • Ages 18 to 90
    • All sexes
    Sponsor
    Amgen
    Recruiting in
    Sioux Falls
    Registry record
    NCT07037758 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in South Dakota on ClinicalTrials.gov.

Prostate cancer: recently updated in South Dakota

  1. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Recruiting in
    Sioux Falls
    Registry record
    NCT04221542 · updated
  2. Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Recruiting in
    Sioux Falls
    Registry record
    NCT07493512 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in South Dakota on ClinicalTrials.gov.

Melanoma: recently updated in South Dakota

  1. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT02332668 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in South Dakota on ClinicalTrials.gov.

Lymphoma: recently updated in South Dakota

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT04726241 · updated
  2. Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

    • Phase 1/2
    • From 6 months, up to 25 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Sioux Falls
    Registry record
    NCT06395103 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in South Dakota on ClinicalTrials.gov.

Ask about studies in South Dakota

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call